Literature DB >> 8679543

Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.

L Zeng1, S An, E J Goetzl.   

Abstract

Cell surface expression of multiple structurally and functionally distinct prostaglandin E2 (PGE2) receptors (Rs), designated the EP1, EP2, EP3, and EP4 Rs, is a principal determinant of the diverse cellular effects of PGE2. The RNK-16 line of rat large granular lymphocytes, which has served as a model for natural killer cells, coexpresses a mean of 1092 EP3 Rs and EP4 Rs per cell with a mean Kd of 2.7 nM. The presence of the EP3 and EP4 Rs and the absence of the EP1 and EP2 Rs were revealed by inhibition of [3H]PGE2 binding by the EP3/EP1R agonist sulprostone, the EP3/EP2/EP4R agonist M&B 28767, and the EP2/EP4/EP3R agonist misoprostol but not by the EP1R antagonist SC-19220 or the EP2R agonist butaprost. Functional EP4 R expression was confirmed by finding that PGE2 and misoprostol, but not butaprost or sulprostone, evoked increases in the intracellular concentration of cyclic AMP ([cAMP]) in RNK-16 cells. Matrix metalloproteinase (MMP)-1 and -3 were identified by zymography and Western blots as the principal MMPs secreted by RNK-16 cells. Secretion of both MMPs by RNK-16 cells attained a maximal level after 24 h of incubation and was enhanced significantly by 10(-9) to 10(-7) M PGE2, 10(-6) M misoprostol, and 10(-4) M dibutyryl cyclic AMP, but not by the EP3R agonist sulprostone. Thus, the effect of PGE2 on RNK-16 cell MMP secretion is mediated by an EP4 R-dependent mechanism involving increases in [cAMP]i. The migration of RNK-16 cells across micropore filters, without or with a layer of Matrigel, was stimulated chemokinetically by PGE2 and misoprostol. PGE2-elicited chemokinesis of RNK-16 cells across a Matrigel model basement membrane, but not across a microfilter alone, was suppressed by the GM 6001 inhibitor of MMP activities. Stimulation of MMP activities in RNK-16 cells by the EP4R thus facilitates migration of the NK cells across vascular basement membranes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679543     DOI: 10.1021/bi960036x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor.

Authors:  M Bastepe; B Ashby
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection.

Authors:  G M Anstead; B Chandrasekar; W Zhao; J Yang; L E Perez; P C Melby
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1.

Authors:  E J Thompson; A Gupta; G A Vielhauer; J W Regan; G T Bowden
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

4.  Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line YT.

Authors:  Karin Edsparr; Frank M Speetjens; Adri Mulder-Stapel; Ronald H Goldfarb; Per H Basse; Bo Lennernäs; Peter J K Kuppen; Per Albertsson
Journal:  J Immunother       Date:  2010-06       Impact factor: 4.456

5.  2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness.

Authors:  S S Chuang; M H Kim; L A Johnson; P Albertsson; R P Kitson; U Nannmark; R H Goldfarb; P A Mathew
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

6.  Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells.

Authors:  N Kvirkvelia; I Vojnovic; T D Warner; V Athie-Morales; P Free; N Rayment; B M Chain; T W Rademacher; T Lund; I M Roitt; P J Delves
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

7.  Involvement of EP1 and EP2 receptors in the regulation of the Na,K-ATPase by prostaglandins in MDCK cells.

Authors:  Keikantse Matlhagela; Mary Taub
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-01-27       Impact factor: 3.072

8.  The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.

Authors:  Durga Prasad Cherukuri; Xiao B O Chen; Anne-Christine Goulet; Robert N Young; Yongxin Han; Ronald L Heimark; John W Regan; Emmanuelle Meuillet; Mark A Nelson
Journal:  Exp Cell Res       Date:  2007-06-22       Impact factor: 3.905

9.  Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation.

Authors:  Karin Edsparr; Per H Basse; Ronald H Goldfarb; Per Albertsson
Journal:  Cancer Microenviron       Date:  2010-11-27

10.  Effect of PGE2-EPs pathway on primary cultured rat neuron injury caused by aluminum.

Authors:  Lu Yang; Yuling Wei; Ying Luo; Qunfang Yang; Huan Li; Congli Hu; Yang Yang; Junqing Yang
Journal:  Oncotarget       Date:  2017-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.